Bal Pharma standalone net profit declines 72.46% in the September 2018 quarter

Sales rise 7.02% to Rs 58.38 crore

Net profit of Bal Pharma declined 72.46% to Rs 0.46 crore in the quarter ended September 2018 as against Rs 1.67 crore during the previous quarter ended September 2017. Sales rose 7.02% to Rs 58.38 crore in the quarter ended September 2018 as against Rs 54.55 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales58.3854.55 7 OPM %9.2310.10 -PBDT2.314.08 -43 PBT1.162.33 -50 NP0.461.67 -72

Powered by Capital Market - Live News